Creative Medical Technology Obtains Exclusive Distribution Rights to Cervos Medical’s Marrow Cellution™ Devices for Use in Urology, Gynecology, and Male and Female Sexual Dysfunction


PHOENIX, March 10, 2022 /PRNewswire/ — Creative Medical Technology Holdings, Inc. (“Creative Medical Technology” or the “Company”) (NASDAQ: CELZ), a leading commercial-stage biotechnology company focused on a regenerative approach to immunotherapy, of urology, neurology and orthopedics, today announced that it has signed an agreement with Cervos Inc. (“Cervos Medical”) to become the exclusive distributor of Marrow Celllution™ devices for use in urology, gynecology and male and female sexual dysfunction.

“This exciting agreement provides us with exclusive access to Cervos Medical’s best-in-class devices for use in many of our leading rapid autologous therapies, including CaverStem® for erectile dysfunction, FemCelz® for female sexual dysfunction and, at launch, OvaStem. ® for women with premature ovarian failure,” said Timothy Warbington, President and Chief Executive Officer of the Company. “With a guaranteed supply of high-quality devices, strong and extensive intellectual property, critical first-mover benefits, established KOLs, and satisfied patients, Creative Medical Technology has a wide gap and is well positioned for success. .”

Harlan AdlerPresident of Cervos Medical, added, “We are excited to expand our relationship with Creative Medical Technology as they continue to advance the regenerative medicine market and showcase the many benefits that bone marrow-derived stem cells of patients can have to improve life. ”

About Creative Medical Technology Holdings

Creative Medical Technology Holdings, Inc. is a commercial-stage biotechnology company specializing in stem cell technology in the fields of immunotherapy, urology, neurology and orthopedics. For more information about the company, please visit

About Cervos Medical

Cervos Medical is a procedure-driven medical device company focused on innovative solutions to enhance natural healing. Cervos Medical’s finest autologous and synthetic orthobiologics mimic and promote vasculogenesis, the body’s natural repair mechanism. Cervos Medical has developed minimally invasive, highly effective, and cost-effective solutions that treat a variety of musculoskeletal disorders, including bone growth, joint preservation, and chronic pain management. Further information about Cervos Medical is available at

Forward-looking statements

This press release may contain forward-looking statements, including, but not limited to, comments regarding the timing and content of upcoming clinical trials and laboratory results, marketing efforts, funding, etc. Forward-looking statements relate to future events and conditions and, therefore, involve risks and uncertainties. Actual results may differ materially from those currently anticipated in these statements. See the periodic and other reports filed by Creative Medical Technology Holdings, Inc. with the Securities and Exchange Commission and available on the Commission’s website at

SOURCE Creative Medical Technology Holdings, Inc.

Source link


Comments are closed.